Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Feb 6, 2022; 10(4): 1432-1440
Published online Feb 6, 2022. doi: 10.12998/wjcc.v10.i4.1432
Published online Feb 6, 2022. doi: 10.12998/wjcc.v10.i4.1432
Inflammatory myofibroblastic tumor after breast prosthesis: A case report and literature review
Peng Zhou, Yi-Hao Chen, Jiang-Hao Lu, Chun-Chun Jin, Xue-Hao Gong, Department of Ultrasound, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen 518035, Guangdong Province, China
Yi-Hao Chen, Xiao-Hong Xu, Xue-Hao Gong, Graduate School, Guangdong Medical University, Zhanjiang 524023, Guangdong Province, China
Xiao-Hong Xu, Department of Ultrasound, Guangdong Medical University Affiliated Hospital, Zhanjiang 524001, Guangdong Province, China
Author contributions: Zhou P and Chen YH contributed equally to this manuscript; Zhou P and Chen YH were responsible for collecting the medical history of the patient and drafting the paper; Lu JH reviewed the literature; Jin CC revised the manuscript; Xu XH revised the manuscript for important intellectual content and edited the figures; Gong XH reviewed and edited the manuscript; all authors issued final approval for the version to be submitted.
Supported by Sanming Project of Medicine in Shenzhen , No. SZSM201612027 ; Clinical Research Project of Shenzhen Second People’s Hospital , No. 20203357001 .
Informed consent statement: Informed written consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflicting interests.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Xue-Hao Gong, MD, Chief Physician, Department of Ultrasound, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University, No. 3002 Sungang West Road, Futian District, Shenzhen 518035, Guangdong Province, China. fox_gxh@sina.com
Received: September 5, 2021
Peer-review started: September 5, 2021
First decision: October 11, 2021
Revised: October 21, 2021
Accepted: December 23, 2021
Article in press: December 23, 2021
Published online: February 6, 2022
Peer-review started: September 5, 2021
First decision: October 11, 2021
Revised: October 21, 2021
Accepted: December 23, 2021
Article in press: December 23, 2021
Published online: February 6, 2022
Core Tip
Core Tip: We believe that our study makes a significant contribution to the literature because inflammatory myofibroblastic tumors (IMTs) of the breast are rare and unique; however, whether they are reactive or neoplastic in nature remains unelucidated. This case presented the opportunity to review studies regarding cases of inflammatory myofibroblastic breast tumors and determine whether they are reactive lesions due to an exaggerated response to tissue injury or indicate a true neoplastic process. This report prompts that prosthesis implantation may cause IMT.